Nurettin Tunc
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Nurettin Tunc has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Abdurrahman Sahin
Gaziosmanpasa University, Faculty of Medicine, Department of Gastroenterology, Tokat, Turkey
1 shared publication Deccane Duzenci
Department of Internal Medicine, Elazig Education and Training Hospital, Elazig, Turkey
1 shared publicationIbrahim Halil Bahcecioglu
Medicine Faculty, Department of Gastroenterology, Firat University, Elazig, Turkey
1 shared publication- Mehmet Yalniz
Department of Gastroenterology, Firat University Faculty of Medicine, Elazig, Türkiye
1 shared publication Semra Turkoglu
Department of Nutrition and Dietetics, Health Sciences Faculty, Firat University, Elazig, Turkey
1 shared publication- Özgen Arslan Solmaz
Department of Pathology, Elazığ Training and Research Hospital, Elazığ, Turkey
1 shared publication
Latest Publications
- Open Access
- 1 March 2018
- Published by Taylor & Francis in Therapeutics and Clinical Risk Management
- Vol. ume 14, 627-635
Is ischemia-modified albumin a reliable tool for the assessment of acute pancreatitis?
Purpose: Oxidative stress has been implicated in several disorders, including acute pancreatitis (AP). Ischemia-modified albumin (IMA), which reflects the ability to bind cobalt, has been found to be elevated in conditions of oxidative stress and tissue hypoxia. This study examined IMA and adjusted IMA levels in patients with AP, and examined the associations of IMA and adjusted IMA levels to the severity of AP. Patients and methods: A total of 42 consecutive patients with AP and 43 age- and sex-matched control subjects were enrolled. Serum samples were obtained from patients with AP on admission as well as 48–72 hours after hospitalization, and from the controls, at the time of enrollment. Adjusted IMA was calculated by multiplying the IMA value of each patient with the ratio of the patient’s albumin value and the median albumin value of the study population. The severity of AP was assessed according to the modified Atlanta classification, and the patients were divided into 2 groups: mild AP and severe AP. Results: The serum IMA and adjusted IMA values of patients with AP on admission and those of the controls did not differ (p=0.86 and p=0.99, respectively). The second measurements of IMA and adjusted IMA in the AP group were higher than the first measurements of both the AP group and controls (for all, pp=0.005). Conclusion: It was shown that IMA and adjusted IMA levels rise with the progression of AP. Lower levels of adjusted IMA predict the severity of AP. Further studies with serial measurements of IMA are warranted to explore the indicative role of IMA in the course of AP.
- 1 March 2018
- Published by Taylor & Francis in Therapeutics and Clinical Risk Management
- Vol. ume 14, 627-635
Open AccessIs ischemia-modified albumin a reliable tool for the assessment of acute pancreatitis?
Purpose: Oxidative stress has been implicated in several disorders, including acute pancreatitis (AP). Ischemia-modified albumin (IMA), which reflects the ability to bind cobalt, has been found to be elevated in conditions of oxidative stress and tissue hypoxia. This study examined IMA and adjusted IMA levels in patients with AP, and examined the associations of IMA and adjusted IMA levels to the severity of AP. Patients and methods: A total of 42 consecutive patients with AP and 43 age- and sex-matched control subjects were enrolled. Serum samples were obtained from patients with AP on admission as well as 48–72 hours after hospitalization, and from the controls, at the time of enrollment. Adjusted IMA was calculated by multiplying the IMA value of each patient with the ratio of the patient’s albumin value and the median albumin value of the study population. The severity of AP was assessed according to the modified Atlanta classification, and the patients were divided into 2 groups: mild AP and severe AP. Results: The serum IMA and adjusted IMA values of patients with AP on admission and those of the controls did not differ (p=0.86 and p=0.99, respectively). The second measurements of IMA and adjusted IMA in the AP group were higher than the first measurements of both the AP group and controls (for all, pp=0.005). Conclusion: It was shown that IMA and adjusted IMA levels rise with the progression of AP. Lower levels of adjusted IMA predict the severity of AP. Further studies with serial measurements of IMA are warranted to explore the indicative role of IMA in the course of AP.